CompoundIQ

Disclaimer

CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.

SteroidAdvancedVery High Risk

Mibolerone

Also known as: Cheque Drops, Mibolerone

Mibolerone (Cheque Drops) is an extremely potent oral anabolic steroid originally developed as a veterinary drug to suppress estrus (heat) in female dogs. It is one of the most powerful androgens ever created, with an androgenic potency roughly 6 times that of testosterone. It is used in underground circles almost exclusively as a pre-competition or pre-workout aggression enhancer.

Evidence30/100 — Emerging

Risk Level

Very High Risk

Difficulty

Advanced
CAS Number3704-09-4
Molecular FormulaC20H30O2
ClassSteroid
CategoryUnderground Steroids

Mechanism of Action

An extremely potent androgen that binds to androgen, progesterone, and glucocorticoid receptors. Has potent anti-gonadotropic activity. Does not aromatize but has intrinsic estrogenic activity at high doses. Its extreme potency is due to multiple structural modifications that enhance receptor binding affinity and oral bioavailability.

Dosing Research

Used in microgram quantities — typically 200-500 mcg (0.2-0.5 mg) taken 30-60 minutes before competition or training. Never used for more than 2-3 weeks due to extreme hepatotoxicity. Not used for physique or mass-building purposes. Exclusively used for acute performance and aggression enhancement.

Side Effects & Risks

Extreme hepatotoxicity — among the most liver-toxic oral steroids per milligram. Severe aggression and behavioral changes. Dramatic HPTA suppression even at microgram doses. Cardiovascular strain. Progestogenic side effects. Potential liver tumors with extended use. Was never intended for human use. One of the most dangerous oral steroids available.

Research Studies

Disclaimer

CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.

Send Feedback

Help us improve CompoundIQ